Document:

Exhibit 10.10

 

AMENDMENT
TO

THE COGNITION THERAPEUTICS, INC.

2017 EQUITY INCENTIVE PLAN

 

WHEREAS, Cognition Therapeutics, Inc.
(the “Company”) has adopted the Cognition Therapeutics, Inc. 2017 Equity Incentive Plan (the “Plan”);

 

WHEREAS, Section 12(a) of
the Plan permits the Board of Directors of the Company (the “Board”) to amend the Plan from time to time;

 

WHEREAS, pursuant to Section 3
of the Plan, as amended, a total of 2,798,908 shares of Common Stock of the Company, par value $.001 per share (“Common Stock”),
plus any share of Common Stock that would otherwise revert to the share reserve of the Company’s Amended and Restated 2007 Equity
Incentive Plan, have been reserved for issuance under the Plan;

 

WHEREAS, the Company desires
to increase the number of shares issuable under the Plan by 1,224,597 shares of Common Stock.

 

NOW, THEREFORE, the following
amendments and modifications are hereby made a part of the Plan subject to, and effective as of the date of, the approval of shareholders
of the Plan as amended:

 

		1.	Section 3(a) of the Plan is hereby amended by revising the first sentence of such section in
its entirety to read as follows:

 

“Subject to adjustment as described
below, the aggregate number of shares of common stock of the Company (“Company Stock”) that may be issued under this Plan
is equal to (i) 4,023,505 and (ii) the number of shares that may be added to this Plan pursuant to Section 3(b) (collectively
the “Share Reserve”), each of which may be granted as an Incentive Stock Option, up to the maximum limit set forth in Section 3(d) below.”

 

		2.	Section 3(d) of the Plan is hereby amended by revising the first sentence of such section in
its entirety to read as follows:

 

“Notwithstanding anything to
the contrary in this Section 3, subject to the provisions of Section 3(e) relating to capitalization adjustments, the aggregate
maximum number of shares of Company Stock that may be issued pursuant to the exercise of Incentive Stock Options shall be 4,203,505 shares
of Company Stock plus the amount of any increase in the number of shares that may be available for issuance pursuant to Grants pursuant
to Section 3(h), but in no event shall greater than 14,413,989 shares of Company Stock be issued as Incentive Stock Options (the
 “Maximum Incentive Stock Option Limit”).”

 

		3.	In all other respects, the Plan, as amended, is hereby ratified and confirmed and shall remain in full
force and effect.Exhibit 10.13

 

COGNITION THERAPEUTICS, INC. 2021 EQUITY INCENTIVE
PLAN

 

RESTRICTED STOCK UNIT GRANT NOTICE AND

AWARD AGREEMENT

 

Cognition
Therapeutics, Inc., a Delaware corporation (the “Company”), pursuant to its 2021 Equity Incentive Plan (the “Plan”),
hereby grants to the individual listed below (“Participant”) the number of restricted stock units set forth below (the
 “Restricted Stock Units”). The Restricted Stock Units described in this Restricted Stock Unit Grant Notice (the “Grant
Notice”) are subject to the terms and conditions set forth in the Award Agreement attached hereto as Exhibit A (the
 “Agreement”) and the Plan, each of which is incorporated herein by reference. Unless otherwise defined herein, capitalized
terms used in this Grant Notice and the Agreement will have the meanings defined in the Plan.

 

	Participant:	[_________]
	 	 
	Grant Date:	[_________]
	 	 
	Total Number of Restricted Stock Units:	[_________]
	 	 
	Vesting Schedule:	[_________]

 

By signing
below, Participant agrees to be bound by the terms and conditions of the Plan, the Agreement and this Grant Notice. This document may
be executed, including by electronic means, in multiple counterparts, each of which will be deemed an original, and all of which together
will be deemed a single instrument.

 

	COGNITION THERAPEUTICS, INC.	 	participant
	 	 	 
	 	 	 	 	 
	Name:	 	Name:
	Title:	 	 

 

     

     

    

 

EXHIBIT A

TO RESTRICTED STOCK
Unit GRANT NOTICE

 

AWARD AGREEMENT

 

1.            Award
of Restricted Stock Units. Effective as of the Grant Date set forth in the Grant Notice, the Company has granted to Participant the
number of Restricted Stock Units set forth in the Grant Notice, subject to the restrictions and on the terms and conditions set forth
in the Grant Notice, the Plan and this Agreement. Each Restricted Stock Unit represents the right to receive one Share at the times and
subject to the conditions set forth herein.

 

2.            Vesting
of Restricted Stock Units.

 

a.            Subject
to the continued service of Participant with the Company through the relevant vesting dates, the Restricted Stock Units will become vested
in such amounts and at such times as set forth in the Grant Notice.

 

b.            Solely
for purposes of this Agreement, service with the Company will be deemed to include service with an Affiliate of the Company (for only
so long as such entity remains an Affiliate of the Company).

 

c.            Upon
Participant’s death during his or her continuous service with the Company, any Restricted Stock Units that are outstanding and
unvested immediately prior to Participant’s death will remain outstanding for ninety (90) days, during which time the Committee
may, in its sole discretion, vest all or a portion of such Restricted Stock Units. If the Committee decides to vest any Restricted Stock
Units under this Section 2.c it may condition such vesting on the execution by the Participant’s estate and/or beneficiaries of
a general release of claims against the Company and its affiliates, in such form as the Company may prescribe (a “Release”).
Upon the ninetieth (90th) day following Participant’s death, any portion of the unvested Restricted Stock Units that the Committee
has not determined to vest in accordance with this Section 2.c will be forfeited.

 

d.            Unless
otherwise provided in the Grant Notice or in Participant’s employment agreement, upon the cessation of Participant’s service
with the Company for any reason other than as described in Section 2.c above, any unvested Restricted Stock Units will be forfeited automatically.

 

3.            Settlement.

 

a.            Shares
will be issued in respect of vested Restricted Stock Units within sixty (60) days following the applicable vesting date or event. For
avoidance of doubt, this settlement timing is intended to comply with the “short-term deferral” exemption from Section 409A
of the Code.

 

b.            The
Restricted Stock Units will not confer on Participant any rights as a stockholder of the Company until Shares are actually issued in
settlement of such Restricted Stock Units.

 

c.            Notwithstanding
the foregoing, to the extent provided in Prop. Treas. Reg. § 1.409A-1(b)(4)(ii) or any successor provision, the Company may delay
settlement of Restricted Stock Units if it reasonably determines that such settlement would violate federal securities laws or any other
applicable law.

 

4.            Non-Transferability
of Restricted Stock Units. Restricted Stock Units may not be sold, pledged, assigned, hypothecated, gifted, transferred or disposed
of in any manner, either voluntarily or involuntarily, other than by will or by the laws of descent and distribution.

 

    1 

     

    

 

5.            Section
409A. The grant of Restricted Stock Units is intended to be exempt from Section 409A of the Code and should be interpreted accordingly.
Nonetheless, the Company does not guarantee the tax treatment of the Restricted Stock Units.

 

6.            No
Continuation of Service. Neither the Plan nor this Agreement will confer upon Participant any right to continue in the employment
or service of the Company or any of its Affiliates, or limit in any respect the right of the Company or its Affiliates to discharge Participant
at any time, for any reason.

 

7.            The
Plan. Participant has received a copy of the Plan, has read the Plan and is familiar with its terms, and hereby accepts the Award
subject to the terms and provisions of the Plan. Pursuant to the Plan, the Committee is authorized to interpret the Plan and to adopt
rules and regulations not inconsistent with the Plan as it deems appropriate. Participant hereby agrees to accept as binding, conclusive
and final all decisions or interpretations of the Committee with respect to questions arising under the Plan, the Grant Notice or this
Agreement.

 

8.            Company
Policies. Participant agrees, in consideration for the grant of the Restricted Stock Units, to be subject to any policies of the
Company and its Affiliates regarding clawbacks, securities trading, and hedging or pledging of securities that may be in effect from
time to time, or as may otherwise be required by applicable law, regulation or exchange listing standard.

 

9.            Entire
Agreement. The Grant Notice and this Agreement, together with the Plan, represent the entire agreement between the parties with respect
to the subject matter hereof and supersede any prior agreement, written or otherwise, relating to the subject matter hereof.

 

10.          Amendment.
This Agreement may only be amended by a writing signed by each of the parties hereto; provided that the Company may amend this Agreement
without Participant’s consent, if the amendment does not materially impair Participant’s rights hereunder.

 

11.          Governing
Law. This Agreement will be construed in accordance with the laws of the State of Delaware, without regard to the application of
the principles of conflicts of laws.

 

12.           Headings.
The headings in this Agreement are for convenience only. They form no part of the Agreement and will not affect its interpretation.

 

13.          Tax
Withholding. Participant acknowledges that the issuance of Shares hereunder will give rise to taxable income subject to required
withholding. In accordance with Section 15 of the Plan, the obligations of the Company hereunder are conditioned on the Participant timely
paying, or otherwise making arrangements satisfactory to the Company regarding the timely satisfaction of, such required withholding.

 

14.          Electronic
Delivery of Documents. Participant authorizes the Company to deliver electronically any prospectuses or other documentation related
to the Option and any other compensation or benefit plan or arrangement in effect from time to time (including, without limitation, reports,
proxy statements or other documents that are required to be delivered to participants in such arrangements pursuant to federal or state
laws, rules or regulations). For this purpose, electronic delivery will include, without limitation, delivery by means of e-mail or e-mail
notification that such documentation is available on the Company’s Intranet site. Upon written request, the Company will provide
to Participant a paper copy of any document also delivered to Participant electronically. The authorization described in this paragraph
may be revoked by Participant at any time by written notice to the Company.

 

    2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}]]